enVVeno Medical Corporation
NVNO
$1.00
$0.033.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.94% | -2.20% | -3.37% | 29.79% | 1.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.27% | -9.98% | 6.71% | 15.35% | -19.96% |
| Operating Income | -12.27% | 9.98% | -6.71% | -15.35% | 19.96% |
| Income Before Tax | -35.07% | 9.80% | -10.27% | -12.82% | 23.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.07% | 9.80% | -10.27% | -12.82% | 23.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.07% | 9.80% | -10.27% | -12.82% | 23.45% |
| EBIT | -12.27% | 9.98% | -6.71% | -15.35% | 19.96% |
| EBITDA | -12.70% | 9.80% | -7.01% | -15.76% | 20.06% |
| EPS Basic | -6.61% | 28.82% | 16.06% | 21.13% | 54.86% |
| Normalized Basic EPS | 13.04% | 31.38% | 20.09% | 19.92% | 53.18% |
| EPS Diluted | -6.61% | 28.82% | 16.06% | 21.13% | 54.86% |
| Normalized Diluted EPS | 13.04% | 31.38% | 20.09% | 19.92% | 53.18% |
| Average Basic Shares Outstanding | 26.67% | 26.75% | 31.38% | 43.06% | 69.63% |
| Average Diluted Shares Outstanding | 26.67% | 26.75% | 31.38% | 43.06% | 69.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |